Literature DB >> 29588542

Human cytomegalovirus reprogrammes haematopoietic progenitor cells into immunosuppressive monocytes to achieve latency.

Dihan Zhu1, Chaoyun Pan1, Jingxue Sheng2, Hongwei Liang1,3, Zhen Bian1,3, Yuan Liu3, Phong Trang2,4, Jianguo Wu5, Fenyong Liu6, Chen-Yu Zhang7, Ke Zen8,9.   

Abstract

The precise cell type hosting latent human cytomegalovirus (HCMV) remains elusive. Here, we report that HCMV reprogrammes human haematopoietic progenitor cells (HPCs) into a unique monocyte subset to achieve latency. Unlike conventional monocytes, this monocyte subset possesses higher levels of B7-H4, IL-10 and inducible nitric oxide synthase (iNOS), a longer lifespan and strong immunosuppressive capacity. Cell sorting of peripheral blood from latently infected human donors confirms that only this monocyte subset, representing less than 0.1% of peripheral mononuclear cells, is HCMV genome-positive but immediate-early-negative. Mechanistic studies demonstrate that HCMV promotes the differentiation of HPCs into this monocyte subset by activating cellular signal transducer and activator of transcription 3 (STAT3). In turn, this monocyte subset generates a high level of nitric oxide (NO) to silence HCMV immediate-early transcription and promote viral latency. By contrast, the US28-knockout HCMV mutant, which is incapable of activating STAT3, fails to reprogramme the HPCs and achieve latency. Our findings reveal that via activating the STAT3-iNOS-NO axis, HCMV differentiates human HPCs into a longevous, immunosuppressive monocyte subset for viral latency.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29588542      PMCID: PMC6537872          DOI: 10.1038/s41564-018-0131-9

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  33 in total

1.  Methods for Studying the Function of Cytomegalovirus GPCRs.

Authors:  Christine M O'Connor; William E Miller
Journal:  Methods Mol Biol       Date:  2021

2.  A novel murine model of differentiation-mediated cytomegalovirus reactivation from latently infected bone marrow haematopoietic cells.

Authors:  Xue-Feng Liu; Suchitra Swaminathan; Shixian Yan; Flora Engelmann; Darryl Adelaide Abbott; Luke Andrew VanOsdol; Taylor Heald-Sargent; Longhui Qiu; Qing Chen; Andre Iovane; Zheng Zhang; Michael M Abecassis
Journal:  J Gen Virol       Date:  2019-12       Impact factor: 3.891

3.  Cell Line Models for Human Cytomegalovirus Latency Faithfully Mimic Viral Entry by Macropinocytosis and Endocytosis.

Authors:  Jeong-Hee Lee; Joseph R Pasquarella; Robert F Kalejta
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

Review 4.  A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System.

Authors:  Anna Bellizzi; Nicholas Ahye; Gauthami Jalagadugula; Hassen S Wollebo
Journal:  J Neuroimmune Pharmacol       Date:  2019-09-11       Impact factor: 4.147

Review 5.  Emerging roles of cytomegalovirus-encoded G protein-coupled receptors during lytic and latent infection.

Authors:  Theresa Frank; Ina Niemann; Anna Reichel; Thomas Stamminger
Journal:  Med Microbiol Immunol       Date:  2019-03-21       Impact factor: 3.402

6.  Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos.

Authors:  Benjamin A Krishna; Monica S Humby; William E Miller; Christine M O'Connor
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-15       Impact factor: 11.205

Review 7.  The B7x Immune Checkpoint Pathway: From Discovery to Clinical Trial.

Authors:  Peter John; Yao Wei; Weifeng Liu; Meirong Du; Fangxia Guan; Xingxing Zang
Journal:  Trends Pharmacol Sci       Date:  2019-10-31       Impact factor: 14.819

Review 8.  Human Cytomegalovirus Host Interactions: EGFR and Host Cell Signaling Is a Point of Convergence Between Viral Infection and Functional Changes in Infected Cells.

Authors:  Byeong-Jae Lee; Chan-Ki Min; Meaghan Hancock; Daniel N Streblow; Patrizia Caposio; Felicia D Goodrum; Andrew D Yurochko
Journal:  Front Microbiol       Date:  2021-05-07       Impact factor: 5.640

9.  CMV-encoded GPCR pUL33 activates CREB and facilitates its recruitment to the MIE locus for efficient viral reactivation.

Authors:  Benjamin A Krishna; Amanda B Wass; Abigail L Dooley; Christine M O'Connor
Journal:  J Cell Sci       Date:  2021-01-25       Impact factor: 5.285

10.  Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies.

Authors:  Timo W M De Groof; Elizabeth G Elder; Eleanor Y Lim; Raimond Heukers; Nick D Bergkamp; Ian J Groves; Mark Wills; John H Sinclair; Martine J Smit
Journal:  Nat Commun       Date:  2021-07-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.